C3is (NASDAQ:CISS – Get Free Report) posted its quarterly earnings data on Tuesday. The company reported $5.24 EPS for the quarter, FiscalAI reports. The business had revenue of $23.15 million for the quarter. C3is had a return on equity of 6.78% and a net margin of 15.28%.
C3is Stock Performance
Shares of NASDAQ:CISS opened at $2.63 on Thursday. The company has a market cap of $394,500.00, a P/E ratio of 0.00 and a beta of 1.39. C3is has a one year low of $2.36 and a one year high of $831.59. The business’s 50-day simple moving average is $5.00 and its 200 day simple moving average is $61.99.
Institutional Investors Weigh In On C3is
Hedge funds have recently modified their holdings of the stock. Citadel Advisors LLC purchased a new stake in C3is during the 3rd quarter worth approximately $29,000. Wexford Capital LP increased its holdings in C3is by 460.1% during the 3rd quarter. Wexford Capital LP now owns 112,014 shares of the company’s stock worth $240,000 after purchasing an additional 92,014 shares during the last quarter. Finally, L1 Global Manager Pty Ltd purchased a new stake in C3is during the 4th quarter worth approximately $198,000. 10.54% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
View Our Latest Stock Analysis on CISS
About C3is
C3is Inc offers international seaborne transportation services. It provides its services to dry bulk charterers, including national and private industrial users, commodity producers and traders, oil producers, refineries, and commodities traders and producers. The company owns and operates a fleet of two drybulk carriers, which transport major bulks, such as iron ore, coal and grains, as well as minor bulks comprising bauxite, phosphate, and fertilizers, and one Aframax crude oil tanker that transports crude oil.
Featured Stories
- Five stocks we like better than C3is
- Freight Boom: The Hormuz Blockade Payday
- The Palantir Paradox—Record Numbers and a Stock That Won’t Cooperate
- TJX Companies Fires on All Cylinders With 9% Revenue Growth
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
Receive News & Ratings for C3is Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for C3is and related companies with MarketBeat.com's FREE daily email newsletter.
